Company Overview

Company name: Pure Global Cannabis
Description: Producer of cannabis-infused products for medical and adult-use markets. The company utilizes pharmaceutical technologies to harness the therapeutic properties of cannabis to produce products such as dried flowers, soft capsules and gels, seedlings and clones, vape pen cartridges, topicals, sublingual strips, transdermal patches, beverages, cannabis oils, and other related products.
Year founded:
Parent company:
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
City: Brampton
State: Ontario
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million):
Business status: Profitable
Ownership: Publicly Held
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company acquired Royal Sapphire (TSX: RSL) through a reverse merger, resulting in the combined entity trading on the TSX Stock Exchange under the ticker symbol PURE on July 06, 2018.
Number of active investors:
Profile last updated: 21-Sep-2018
Last known valuation:
Last known valuation date: